Abstract
This review provides an outline of how our understanding of the neuroendocrine control of the hypothalamo-pituitary–gonadal axis has evolved since the publication of Geoffrey Harris' renowned monograph in 1955. Particular attention is directed to the neurobiology underlying pulsatile GnRH release from the hypothalamus, the neuroendocrine control of ovarian cycles, puberty and seasonality of gonadal function, and to ideas that have emerged as a result of examining the relationship between growth and the reproductive axis. The review closes with i) a brief discussion of how knowledge gained as a result of pursing the early hypotheses of Harris has led to major clinical and therapeutic applications, and ii) a personal glimpse into the future of research in this fascinating area of biology.
Introduction
In the fourth chapter of Geoffrey Harris' widely acclaimed monograph (Harris 1955), which now 60 years later provides the corner stone of this special issue of the journal, he succinctly and systematically presented his views, and the evidence upon which they were based, on the neural mechanisms controlling the pituitary–gonadal axis. That gonadal function was under control by the CNS was well established at the time of Harris' monograph, as was the recognition of the gonad-stimulating properties of pituitary gonadotropin, the relative insignificance of gonadal nerves to gonadal function and the concept of neurosecretion. The problem for Harris and his fellow neuroendocrinologists was how did the hypothalamus regulate the secretion of the anterior pituitary hormones, specifically gonadotropin in the context of this review, and what the role was of the hypopophysial portal system in this regard. After elegantly interpreting and summarizing the extant data, Harris proposed that of the hypotheses that were being debated at the time, ‘the most likely seems to be that nerve fibres from the hypothalmus liberate some humoral substance(s) into the capillaries of the primary plexus in the median eminence and that this substance is carried by the portal vessels to excite or inhibit the cells of the pars distalis’. It is to be recalled, that this idea had been proposed by Harris and Green on several occasions prior to publication of the monograph (Harris 1955). It is also worth noting that the evidence upon which Harris' hypothesis was based had been obtained primarily from studies of the female, most likely because ovulation was a discrete and readily detected event and, at the time, the only reliable surrogate marker of acute hypothalamic activation.
The main purpose of this Thematic Review is to describe the essential refinements and additional complexities that have been added to the fundamental model Harris put forward in 1955 for the neuroendocrine control of gonadal function (Fig. 1). The major additions to the neuroendocrinologist's armamentarium that have facilitated the development of the ideas of Harris are, according to an historical timeline, the introduction of RIA to measure concentrations of pituitary and gonadal hormones in the peripheral circulation and gonadotropin-releasing hormone (GnRH) in portal blood, development of immunohistochemical techniques to localize neuropeptides and neurotransmitters in the hypothalamus, application of techniques in molecular endocrinology to the study of gene expression in the hypothalamus and pituitary, introduction of transgenic models, advances in molecular genetics, and the arrival of the ‘omics’ era. After discussing refinements to the Harris model resulting from the application of the foregoing technologies, this review will close with a brief outline of ways in which knowledge of the operation of this neuroendocrine axis has been applied to clinical practice, and a personal glimpse into the future of this field.
Harris' ‘humoral’ substance (GnRH) and its mode of release
After many years of herculean effort, a struggle between two rival laboratories and many setbacks (recounted by Nicholas Wade in The Nobel Duel (Anchor Press/DoubleDay, 1981) and in a series of three articles published in Science in April/May, 1978), the isolation of the humoral substance of hypothalamic origin that is secreted into the hypophysial portal circulation to regulate the synthesis and secretion of the gonadotopins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), was independently achieved from bovine and ovine brain by the groups of Schally and Guilleman respectively. Ironically this work was published in 1971, the year of Harris' death (Amoss et al. 1971, Matsuo et al. 1971). It was a decapeptide that was initially termed LH-releasing hormone or LH-releasing factor (LRF), but the molecule is now generally referred to as GnRH1 (in this review GnRH1 (mammalian GnRH) will be referred to as GnRH). For their labors, Schally and Guilleman were awarded the Nobel Prize in Physiology or Medicine in 1977. Had it not been for Harris' untimely death at an age of 58, he surely would have shared this most prestigious award for laying the conceptual underpinnings of Schally and Guilleman's work.
In 1969, 2 years before Schally and Guilleman reported the isolation of GnRH, Knobil's laboratory studying the ovariectomized rhesus monkey had found that LH was secreted in a pulsatile or episodic manner with a frequency in the agonadal condition of approximately one pulse per hour. They proposed that this pulsatile mode of LH secretion may be due to intermittent signals from the CNS that are relayed to the pituitary by an LRF (Dierschke et al. 1970, Knobil 1992). Knobil's laboratory went on to demonstrate in 1978, that intermittent GnRH stimulation of the pituitary was essential for sustained secretion of both LH and FSH (Belchetz et al. 1978, Fig. 2). Interestingly, it was not until 1982, after Clarke & Cummins (1982) had developed a technique to sample portal blood in the unsedated ewe, that the episodic nature of hypothalamic GnRH release was empirically demonstrated by these investigators (Fig. 3). Together, the foregoing findings provided the foundation for the concept that pulsatile GnRH release was driven by a neural timing mechanism resident in the hypothalamus (Karsch 1980, Pohl & Knobil 1982) that subsequently came to be known as the hypothalamic GnRH pulse generator. However, it was a later observation that the episodes of LH release in ovariectomized monkeys were tightly coupled to brief increases in multiunit electrophysiological activity recorded in the mediobasal hypothalamus (MBH; Wilson et al. 1984) that led to the general acceptance of the notion of a GnRH pulse generator. This hypothalamic mechanism drives ‘basal’ or ‘tonic’ gonadotropin secretion that, in the female, is responsible for folliculogenesis, maintenance of the corpus luteum and the synthesis of ovarian hormones and, in the male, for maintaining spermatogenesis and testosterone secretion (Plant & Marshall 2001, Zeleznik & Plant 2015).
Ovulation at the end of the follicular phase of the ovarian cycle is triggered by a massive and relatively prolonged discharge of gonadotropin, a mode of release termed ‘surge’ secretion. The view held by Harris that ovulation was under neural control was in part based on the classical studies by Everett & Sawyer (1950) indicating that, in the rat, a recurring daily neural signal was generated by the hypothalamus during a brief critical period in the light phase of the 24 h cycle, and which, on the day of proestrus, was responsible for eliciting the pre-ovulatory gonadotropin surge from the pituitary. The prediction that this neural signal was relayed to the pituitary by Harris' humoral substance was confirmed when Fink et al. demonstrated a large surge in the concentration of GnRH in portal blood during the critical period of the proestrus rat (Sarkar et al. 1976). The neural mechanism responsible for the preovulatory surge of GnRH that occurs over a period of several hours is now conceptualized as the GnRH surge generator. The precise relationship between the GnRH neurons mediating surge and pulsatile release of the decapeptide, however, remains to be determined.
Other ‘humoral’ substances regulating gonadotroph function
The notion that regulation of anterior pituitary hormone secretion by humoral substances from the hypothalamus might be achieved by inhibiting the cells of the pars distalis was built into the Harris hypothesis. In the context of the hypothalamo-pituitary–gonadal axis, evidence for such an inhibitory control system was obtained in studies of Japanese quail in 2000 reporting that a neuropeptide belonging to the RFamide related peptide (RFRP) family (the carboxyl terminal of these peptides is preceded by the amino acid sequence, LP(LorQ)RFamide (Tsutsui et al. 2012)) was found to be concentrated in the external zone of the median eminence of quail and, in vitro, inhibited LH secretion from the pituitary of these birds (Tsutsui et al. 2000). RFRPs were known to exhibit a wide range of biological actions and Tsutsui et al. termed the peptide they had discovered in the quail brain, gonadotropin inhibitory hormone (GnIH). Subsequent studies have demonstrated that GnIH not only regulates gonadotropin secretion in avian species by a direct action on the pituitary but also by an indirect action at the hypothalamic level to modulate GnRH release (Tsutsui et al. 2012). GnIH is not expressed in mammalian brain but two related peptides, RFRP-1 and RFRP-3, are encoded by a gene orthologous to that encoding avian GnIH (Tsutsui et al. 2012). Evidence that RFRPs serve a hypophysiotropic role in the control of the pituitary–gonadal axis of mammalian species in general, however, is tenuous (Herbison 2015).
The GnRH neuron (birth, location, morphology and electrophysiology)
Two years after the structure of GnRH was announced, the first antibody to the peptide was reported (Barry et al. 1973) and since then numerous studies of the immunohistochemical distribution of GnRH neurons in the developing and mature hypothalamus have been conducted (Herbison 2015). Based on careful examination of the embryonic mouse brain the groups of Pfaff and Wray in 1989 independently proposed that GnRH neurons are born in the olfactory placode and after entering the forebrain during early embryonic development migrate to the hypothalamus where several hundred of these cells are found diffusely distributed in the preoptic area (POA) and more caudal areas in the MBH (Schwanzel-Fukuda et al. 1989, Wray et al. 1989). As may be expected from such an amazing journey through the brain, the neurobiology of GnRH neuron migration is complex and involves the interplay of guidance cues, adhesion molecules, growth factors and neurotransmitters (Wierman et al. 2011).
In the adult hypothalamus, the typical GnRH neuron has two dendritic projections, which, as revealed by studies conducted with contemporary morphological techniques over the last 10 years, may extend remarkable distances (2–3 mm) from the cell body or perikaryon (Herbison 2015, Fig. 4). Not surprisingly, a principal target of hypothalamic GnRH neurons is the primary plexus of the hypophysial portal system in the median eminence. Interestingly, the latter projections combine characteristics of both dendrites and axons and have been termed ‘dendrons’ by Herbison et al. (Herde et al. 2013). While considerable attention has been paid to the electrophysiology of the GnRH neuron and the underlying ion channels in the membrane of the cell body, a meaningful correlation between electrical activity and intermittent terminal release of GnRH, as classically demonstrated for oxytocin neurons, has yet to be obtained.
GnRH biosynthesis and action
GnRH is encoded by the GNRH1 gene, which was cloned by Seeburg & Adelman (1984). As pointed out by Herbison (2015), GnRH neurons maintain a high content of their peptide, and it is therefore unlikely that regulation of GNRH1 expression plays a critical role in moment-to-moment control of either GnRH surges or pulses. GnRH action on the pituitary gonadotroph is mediated by G-protein-coupled receptors (GPRs) that signal via Gq and or G11 to activate phospholipase-C that leads to mobilization of Ca++ by inositol phosphate3 (McArdle & Roberson 2015).
Neurobiology of the hypothalamic GnRH pulse generator
The concept of the hypothalamic GnRH pulse generator that emerged in the 1980s remained for more than 20 years in the realm of a ‘black box’. One school of thought proposed that pulsatility was intrinsic to the GnRH neurons themselves and that extensive inter-cellular mechanisms orchestrated synchrony within the network. A second school argued that non-GnRH neurons in the MBH target the GnRH neuronal network directly and drive intermittent release of GnRH (Herbison 2015). The later position has gained increasing support since 2003 when, in the context of the neuroendocrine axis governing the gonad, the power of molecular human genetics to identify novel signaling pathways was dramatically revealed. In that year, two independent groups, led by de Roux and Seminara in Paris and Boston, reported that loss-of-function mutations in a GPR, known as GPR54, was associated with hypogonadotropic hypogonadism in men and women (de Roux et al. 2003, Seminara et al. 2003). The cognate ligand of GPR54 turned out to be a 54 amino acid RFRP known as metastin or kisspeptin. The gene encoding kisspeptin, KISS1, had been of interest to cancer biologists since 1996 when it was found to be a tumor suppressor gene, but, quite remarkably, neither the gene nor the peptide was known to the neuroendocrine community in 2003. Since then, however, it has emerged in a volcanic manner that kisspeptin is an exceptionally potent GnRH secretagogue, GPR54 (the kisspeptin 1 receptor (KISS1R)) is expressed by GnRH neurons, kisspeptin neurons target the GnRH neuronal network, and one population of kisspeptin neurons is located in the arcuate nucleus (Herbison 2015), a periventricular structure located immediately above the median eminence that was originally argued by Knobil's laboratory to be the primary structure mediating the hypothalamic control of gonadotropin secretion in the primate (Knobil 1980).
As a result of the foregoing findings, the idea that kisspeptin might be a component of the GnRH pulse generator, possibly the output of the black box, began to develop. The process was greatly reinforced by another signal observation resulting from the study of human genetics. In late 2009, Topaloglu et al. (2009) reported that loss-of-function mutations in both ligand and receptor in another neuropeptide signaling pathway, namely that of neurokinin B, resulted in a phenotype similar to that described earlier for mutations of GPR54. The significance of this finding was greatly amplified by the fact that Goodman et al. (2007) had 2 years earlier described the expression of neurokinin B in kisspeptin neurons in the arcuate nucleus of the ewe. Thus, in 2010, the community of reproductive neuroendocrinologists began to grapple with the fascinating observation that a subset of neurons in the arcuate nucleus co-express two peptides, each of which appeared to be obligatory for gonadal function in man. Goodman et al. (2007) had also noted that the kisspepeptin/neurokinin B neurons in the arcuate nucleus of the ewe co-expressed a third peptide, dynorphin, an endogenous opioid and one inhibitory to GnRH release. Based upon the first letter of each of these peptides, the acronym, KNDy, was coined to describe these neurons (Cheng et al. 2010). In contrast to dynorphin, neurokinin B is generally stimulatory to GnRH release. Additional information obtained over the last decade has permitted the formulation of a model for GnRH pulse generation (Fig. 5) that posits this hypothalamic timing mechanism is initiated in the KNDy neuronal network of the arcuate nucleus by a reciprocating interplay of stimulatory neurokinin B signals and inhibitory dynorphin inputs (Rance et al. 2010, Wakabayashi et al. 2010, Goodman & Inskeep 2015). As mentioned previously, the output of the pulse generator is posited to be relayed from the arcuate nucleus to the GnRH neuronal network by release of kisspeptin from axonal terminals originating from KNDy neurons. According to this model, kisspeptin of arcuate nucleus origin should be viewed simply as a GnRH pulse generating peptide (Terasawa et al. 2013).
It is probably no exaggeration to say that the discovery of the impact of loss-of-function mutations in GPR54 on the reproductive axis led to a profound and much needed revitalization to the study of GnRH neuroendocrinology, a field that had begun to stagnate in the 1990s.
Neuroendocrine control of ovarian cycles
In spontaneously ovulating species of mammal, the typical ovarian cycle is characterized by the secretion of relatively low basal or tonic levels of LH and FSH, which are interrupted approximately once every 4–5 days in rats and mice and once every 28 days in women, by a massive discharge or surge of gonadotropin which triggers ovulation. Tonic gonadotropin secretion during the follicular phase of the cycle, which drives folliculogenesis, is governed by a negative feedback loop in accordance with the Harris model (Fig. 1). The principal ovarian component of the loop is estradiol (E2) secreted by the developing follicle(s), and it is now established that such feedback occurs at the pituitary level as well as at the hypothalamus. At the hypothalamic level, E2 negative feedback appears to be exerted primarily by modulating the amplitude of pulsatile GnRH release (Zeleznik & Plant 2015). Two nuclear estrogen receptors (ERs) exist, ERα and ERβ, and studies using transgenic mice null for these proteins indicate that ERα is the likely ER mediating the negative feedback action of E2. Interestingly, GnRH neurons do not appear to express ERα, as initially demonstrated by binding studies (Shivers et al. 1983) and subsequently confirmed by immunohistochemistry; therefore E2 negative feedback at the level of the hypothalamus must be mediated indirectly either by non-GnRH neurons or glia. Classical studies have indicated that the locus of the negative feedback action of E2 is within the MBH and, intuitively, it might be expected that ERα expressing KNDy neurons in the arcuate nucleus are the neuronal phenotype targeted. Intriguingly, however, a recent study by Levine et al. employing transgenic mice null for ERα in kisspeptin neurons (not restricted to KNDy neurons) has failed to support this notion (Dubois et al. 2015). On the other hand, Herbison's group using genetically engineered adult female mice and adeno-associated virus injection into the arcuate nucleus to delete ∼75% of ERα positive cells in this nucleus abolished chronic negative feedback action of E2 on LH secretion (Yeo & Herbison 2014) (acute suppression of LH by E2, however, was preserved). It would seem reasonable to conclude that, in the later study, the majority of KNDy neurons would be null for ERα, and therefore the results of the two studies are difficult to reconcile. One possible explanation is that embryonic loss of ERα in kisspeptin neurons may have led to the development of compensatory feedback mechanisms.
During the later half of the follicular phase of the menstrual cycle, the secretion of FSH is suppressed to a greater degree than that of LH, and this differential pattern of gonadotropin release plays a pivotal role in the selection of the pre-ovulatory follicle (Zeleznik & Plant 2015). The mechanism underlying differential suppression of gonadotropin secretion at this stage of the menstrual cycle has not been extensively studied but appears to involve E2 negative feedback action at the level of the pituitary to regulate the constitutive component of FSH release, which is greater than that of LH (Zeleznik & Plant 2015).
In those species with a prolonged luteal phase, such as primates and sheep, progesterone secretion by the corpus luteum markedly retards the frequency of the GnRH pulse generator (Goodman & Inskeep 2015, Zeleznik & Plant 2015). As there is little evidence for progesterone receptor (PR) expression by GnRH neurons, the suppressive feedback action of progesterone on GnRH release, like that of E2, is probably indirect. The finding that KNDy neurons in the ewe hypothalamus express PR suggests that these cells may be the target for progesterone's negative feedback action. However, the impact of ablating PR selectively in KNDy neurons has yet to be examined probably because such genetic approaches have been largely limited to mice, which do not have prolonged luteal phases. It should also be noted that the physiological significance of progesterone's ability to decelerate the frequency of pulsatile GnRH/LH remains unclear because corpus luteum function appears to be normal in GnRH deficient monkeys and women receiving invariant intermittent GnRH replacement (Zeleznik & Plant 2015). In this regard, E2 and inhibin (primarily inhibin A) are also secreted by the corpus luteum and both are capable of inhibiting gonadotropin secretion.
The importance of ovarian steroid feedback for the surge in LH secretion required for ovulation at the end of the follicular phase was suspected at the time Harris' monograph was published. Although Harris was appreciative of these ideas (Harris 1969), he was primarily focused on the nature of the hypothalamic factor that triggered the ovulatory discharge of LH, and it was not until Goding et al. (1969) convincingly demonstrated the ‘positive’ feedback action of estrogen on gonadotropin secretion by showing that administration of E2 to the anestrous ewe elicited an LH surge comparable to that seen spontaneously at the end of the follicular phase during the breeding season.
By this time, Halasz and Gorski had shown by surgically isolating the POA from the MBH of the rat with a bayonet shaped knife that the more rostral area was essential for ovulation in this species (Halasz & Gorski 1967). The knife used for this procedure has become known as the 'Halasz' knife, which was developed by Halasz at Pecs University Medical School. The group at Pecs was one of the major world centers studying the hypothalamic control of the anterior pituitary at the time of Harris, and is perhaps most famous for its studies of hypothalamic pathways and regions (including those that are sensitive to target hormones from the gonad, adrenal and thyroid) underlying the feedback control of anterior pituitary function (Szentagothai et al. 1968).
Together, the foregoing findings suggested that a major site of the positive feedback action of E2 in the rodent was in the POA, and Goodman (1978) went on to verify this idea by demonstrating that implants of crystalline E2 in the POA of the rat were more effective at eliciting LH surges than those implanted in the more caudal region of the hypothalamus. Almost 30 years from the time that Everett & Sawyer (1950) had demonstrated that the generation of a daily neural signal for ovulation in the rat was tightly coupled to the 12 h light:12 h darkness cycle, a comprehensive model for the control of ovulation in the rat had finally begun to emerge. It should also be pointed out that, at this time, evidence was accumulating to indicate that this model might not be applicable to other species. Interestingly, the model for the rat ovarian cycle remained essential unchanged until the recognition in 2003 of the significance of kisspeptin in the regulation of GnRH secretion. During the subsequent 5 years and largely as a result of work by Steiner's laboratory it became apparent that a second hypothalamic population of kisspeptin neurons are located in the anteroventral periventricular (AVPV) nucleus of the POA and that this rostral population is a major site for the positive feedback action of E2 in rodents (Oakley et al. 2009). As with the negative feedback action of E2, knockout studies of ER in mice indicate that ERα mediates the positive feedback of the steroid (Dubois et al. 2015).
In the mid-1970s, Knobil's group threw much of the field of reproductive neuroendocrinology into a state of partial shock when they demonstrated that ovulation occurred in the monkey after neural connections between the POA and MBH were severed using a Halasz knife (Krey et al. 1975). The furor continued when this group proposed that the role of hypothalamic GnRH release in dictating the menstrual cycle was permissive (Knobil et al. 1980). In other words, the only hypothalamic input that was needed for ovarian cycles and ovulation in highly evolved primates was an invariant intermittent stimulation of the pituitary by GnRH and that the characteristic cyclic pattern of gonadotropin secretion was dictated solely by the negative and positive feedback actions of E2 directly at the pituitary: a positive feedback action of E2 in the POA and a GnRH surge was not required. Since then, the most compelling evidence in support of this hypothesis has been obtained from GnRH deficient women, such as those with Kallmann syndrome, where replacement treatment with an invariant intermittent infusion of ‘physiological’ pulse doses of GnRH will drive cycles and ovulation (Zeleznik & Plant 2015). Moreover, indirect evidence indicates that spontaneous ovulation in normal women likely occurs in the absence of a GnRH surge (Zeleznik & Plant 2015). Whatever the final resolution of this important comparative question, it appears that ovulation in the human female is largely emancipated from control by the POA (Plant 2012).
Neuroendocrine control of testicular function
The study of the neuroendocrine control of the testis in the post Harris era has continued to play second fiddle to that of the ovary. As with early studies, upon which the foundations of reproductive neuroendocrinology were laid, ovulation and the pre-ovulatory LH surge, have provided a robust read-out of hypothalamic activation and one that could by easily harnessed to indirectly explore the neurobiological mechanism controlling GnRH secretion. As discussed later, the GnRH surge generator in the rodent is decommissioned during perinatal development, and the hypothalamic control of the testis can be accounted entirely by GnRH pulse generation. Since fundamental sex differences in the control of this mode of GnRH release have yet to be identified, it is to be anticipated that what we understand of GnRH pulse generation in the female will be largely translatable to the male. With regard to the negative feedback control of testicular function, the concept of an aqueous testicular feedback signal ‘inhibin’ was proposed more than 20 years before the publication of Harris' monograph. It was not until 1985, however, that the nature of inhibin was independently revealed by four groups (Vale et al. 1988). Interestingly, follicular fluid not testicular tissue/fluid was used for isolation of the inhibins, which are heteromeric peptides consisting of an α-subunit and one of two β-subunits (Vale et al. 1988). Studies of the male monkey have provided the most convincing evidence to date for a major role of testicular inhibin B (αβB dimer) in regulating the secretion of FSH by a direct negative feedback action at the level of the pituitary (Majumdar et al. 1995).
Neuroendocrine control of puberty
Although Harris' proposal in 1955 that puberty is triggered by a hypothalamic stimulus that is transmitted via the hypophysial portal vessels to the pituitary is now well established, the mechanism underlying the timing of this critical development event in our own species remains an intriguing mystery. Major conceptual advances, however, have been achieved. Studies in the 1980s of pituitary and plasma gonadotropin content in the human and sheep fetus by Grumbach et al. (Sklar et al. 1981, Clark et al. 1984) and of circulating testosterone and LH levels in infantile boys and monkeys by others (Forest et al. 1974, Plant 1980, Waldhauser et al. 1981) led to the deduction that i) GnRH pulse generation in these species develops in the fetus shortly after GnRH neurons complete their embryonic migration from the olfactory placode to the hypothalamus and ii) robust pulsatile GnRH and gonadotropin release is manifest during infancy in highly evolved primates. Puberty, however, is not initiated during infancy because at this stage of development the somatic cells of the gonads that underpin gametogenesis are unable to respond fully to such gonadotropin stimulation. Although the ability of the prepubertal gonad to respond to gonadotropin stimulation is acquired during childhood, by then a hypogonadotropic state is in place as a result of the suppression of pulsatile GnRH release thereby guaranteeing the continued quiescence of the gonad in boys and girls. Interestingly, studies of the monkey indicate that the GnRH neuronal network of the juvenile primate, like the pituitary and gonad at this stage of development, is not limiting to the onset of puberty. This view is based on the finding that in the monkey intermittent neurochemical stimulation of the juvenile hypothalamus with a glutamate receptor agonist will lead with surprising ease to an adult like pattern of pulsatile GnRH release and precocious puberty (Fig. 6, Plant et al. 1989). Moreover, compelling evidence is now at hand indicating that the proximal stimulus responsible for the activation of robust GnRH pulsatility at the onset of spontaneous puberty is indeed an intermittent release of kisspeptin that is generated by the reawakening of the GnRH pulse generator in the arcuate nucleus (Terasawa et al. 2013). The mechanisms that turn the GnRH pulse generator off during infancy, maintain it in a state of suspended animation during juvenile development, and reawaken it at the termination of juvenile development are poorly understood (Plant et al. 2015) and provide a major challenge for the future.
Perinatal programming of the GnRH surge generator
With regard to sexual differentiation of the hypothalamus, Harris stated in 1955, ‘in view of the fact that Pfeiffer (1936) showed prepubertal testis grafts in female rats produce a constant oestrous state after puberty, and that ovaries grafted into adult male rats castrated at birth do undergo cyclic changes, it seems that some neural structure in the male animal becomes differentiated and fixed in its function under the influence of androgens in early life’, a position shared by Everett et al. (1949). Examination of this hypothesis in the post-Harris era has proceeded somewhat in parallel with development of the model for the neural control of ovulation in the rodent, and the target of testicular testosterone action to defeminize the rodent brain is considered to reside within the POA and to involve a negative impact of testicular androgen on the development of kisspeptin neurons in the AVPV (Oakley et al. 2009). An interesting feature of this perinatal decommissioning of the GnRH surge mechanism by testicular testosterone is that the action of the steroid in target neurons within the POA appears to be mediated by ER signaling after intracellular aromatization of testosterone to E2 (Gonzalez-Martinez et al. 2008).
One important comparative aspect of perinatal programming of the GnRH surge system in spontaneous ovulators that has emerged since the time of Harris is the recognition that, in the monkey and probably in man, the neural mechanism underlying the pre-ovulatory LH surge is not decommissioned by the testis during early development. This was first demonstrated by Knobil's laboratory by the finding that unequivocal estrogen-induced LH surges were readily elicited in adult male monkeys castrated postpubertally and implanted with E2 containing Silastic capsules that produced follicular phase levels of the steroid in the agonadal situation (Karsch et al. 1973). A more sensational demonstration followed when Spies' laboratory reported that ovarian cycles and ovulation unfolded in an adult male castrate bearing a subcutaneous ovarian graft (Fig. 7, Norman & Spies 1986).
Modulation of GnRH pulsatility
At the time Harris wrote his monograph in 1955, he discussed the impact of food, temperature, light, social factors and emotional states (in women) on ovarian cycles and fertility, and argued that these modulators of gonadal function are registered by the CNS, which then relays the respective exteroceptive or interoceptive cue to the gonad by controlling gonadotropin secretion from the pituitary. Although considerable advances have been made in our understanding of the neural and neuroendocrine mechanisms involved in such modulation, a complete review of these falls beyond the scope of this review. Instead, two examples that are of particular conceptual significance are discussed.
The first concerns the relationship between somatic and sexual development, and specifically the question of how information on growth is relayed to the reproductive axis. Kennedy & Mitra (1963) proposed that, in the rat, body weight was an initiating factor in the onset of puberty, and inspired by this idea, Frisch and Revelle examined the relationship between body weight and the timing of menarche in girls. The observations of the latter workers led them to propose in 1970 (Frisch & Revelle (1970)), ‘that attainment of body weight in the critical range causes a change in metabolic rate, which, in turn, is responsible for an increase in hypothalamic drive to the pituitary gonadotroph’. An extension of this idea would be to propose that a ‘metabometer’ in the hypothalamus tracks information on metabolism and sends a cue to the GnRH pulse generator when a pubertal metabolic state develops. While this hypothesis has not been systematically examined, interest in the idea of Frisch was reawakened in 1994, by the cloning of the obese gene encoding leptin (Zhang et al. 1994), an adipocyte hormone that plays a major role in regulating appetite and food intake. Although it is now generally recognized that leptin is not the trigger timing the pubertal reawakening of the GnRH pulse generator, this hormone is essential, in a permissive sense, for robust GnRH pulsatility in general, and therefore for both pubertal and adult gonadal function. The latter view is best supported by the finding that in young children with leptin deficiency initiation of treatment with recombinant leptin does not induce puberty immediately but rather only after appropriate somatic development has been attained following prolonged exposure to the hormone (Farooqi & O'Rahilly 2014). Although KNDy neurons in the arcuate nucleus of the hypothalamus were initially thought to be the target of leptin's hypothalamic action to modulate the pituitary–gonadal axis, more recent studies using transgenic mice suggest that the neurobiology underlying the action of leptin to modulate GnRH pulsatility may be considerably more complex (Donato et al. 2011).
The second modulator of GnRH pulsatility to be discussed is photoperiod, a major factor determining annual changes in gonadal function in mammalian species that breed seasonally. Of all the areas of reproductive neuroendocrinology that interested Harris, the study of season in the post-Harris era has arguably uncovered the most novel of insights into neuroendocrine control systems governing the hypothalamic–pituitary–gonadal axis. The story begins with the recognition in the mid-1960s of the importance of the pineal gland in regulating seasonal changes in gonadal function in the Syrian hamster. Melatonin secreted by the pineal is the major signal relaying information on duration of daylight to the hypothalamus, and a major site of action of melatonin in the hypothalamus is the pars tuberalis, a portion of the anterior pituitary that forms a funnel like structure around the pituitary stalk and median eminence. The initial suggestion that the pars tuberalis was instrumental in mediating seasonal changes in anterior pituitary function came from a study by Lincoln & Clarke (1994) employing an experimental preparation in which the pituitary of sheep was disconnected from neurovascular control by the hypothalamus. Such hypothalamo-pituitary disconnected animals continued to exhibit a seasonal rhythm in prolactin secretion. Importantly, gonadotropin levels on the other hand were routinely low due to the blockade of the GnRH signal by the surgical procedure. At about the same time, Karsch's laboratory studying the ewe was systematically exploring an earlier idea of others that thyroid hormone was required for seasonal changes in hypothalamic–pituitary function. Their work demonstrated that thyroid hormone was permissive for the transition to anovulation during the long days of spring, but not needed for return of reproductive function at the start of the fall breeding season (Karsch et al. 1995). Insight into the neurobiology underlying the interaction between thyroid hormone and the seasonal melatonin signal came initially from the finding in Japanese quail (a long-day breeder), that expression in the MBH of a thyroid hormone metabolizing enzyme (type 2 deiodinase) that increases the local concentration of triiodothyronine, the active cellular metabolite of thyroid hormone, was upregulated by exposure to long days (Yoshimura et al. 2003). Interestingly, long days also result in an increase in hypothalamic thyroid hormone activity in short day breeders such as sheep. In both cases, the link between melatonin action in the pars tuberalis and deiodinase activity in the MBH appears to be provided by increased synthesis of thyroid-stimulating hormone in the pars tuberalis triggered by long days (Fig. 8). How low day induced increases in thyroid hormone activity in the MBH either terminate or reactivate pulsatile GnRH release in long and short day breeders, respectively, remains to be established, although KNDy neurons and RFRP expressing neurons have been implicated. As pointed out by Hazlerigg et al. (Hanon et al. 2008), information in this intriguing pathway moves in the opposite direction to that in Harris' model (Fig. 1), albeit without the need of the hypophysial portal circulation, and therefore is unlikely to have been envisioned by Harris. An excellent review of this fascinating control system has recently been published by Hazlerigg & Simonneaux (2015).
Bench to bedside
The isolation and characterization of GnRH, together with the demonstration that sustained stimulation of gonadotropin secretion may be achieved with intermittent stimulation of the pituitary whereas continuous exposure of the gland to the peptide leads to desensitization and thus suppression of gonadotropin secretion, provides the conceptual framework for the current therapeutic uses of GnRH receptor analogs. As comprehensively reviewed by Millar & Newton (2013), GnRH agonists and antagonist are currently used widely to treat gonadal steroid dependent cancers, and disorders of reproductive development including GnRH dependent precocious puberty. These agents are also used extensively in fertility clinics where controlled cycles of follicular development and oocyte maturation are required for egg retrieval and IVF. Millar and Newton also speculate that in the future kisspeptin and neurokinin B analogs may offer additional or improved therapeutic interventions to modulate LH and FSH release. In this regard, a recent report describes successful oocyte maturation following an LH surge induced by a single s.c. injection of kisspeptin administered at the end of the follicular phase of a controlled cycle of ovarian stimulation (Jayasena et al. 2014). It remains to be determined, however, whether kisspeptin induced LH release has any advantages over GnRH induced LH release for oocyte maturation in such a clinical setting.
The future
Harris' model of the control of gonadal function has, over the last 60 years, served as a solid framework for those studying mechanisms that govern how the brain regulates the pituitary–gonadal axis. It has stood the test of time and revisions to the paradigm, while quite remarkable, have been primarily those at the level of cellular and molecular detail, rather than those with major conceptual implications. Perhaps an exception to this generalization is the further recognition that during evolution different mammalian species have coopted different neuroendocrine control systems, or perhaps more precisely utilized a set of neuroendocrine controls to variable degrees, to achieve regulation of the gonad. The implication of the latter view to the future of the field in general is that diversity in the selection of animal models is beneficial, while the interrogation of problems that at the time appear immediately translatable to human health and well being to the exclusion of others is not. With regard to the issue of diversity in selecting animal models, the recent introduction of a technology known as CRISPR–Cas9, which is potentially capable of being used to edit the genome of any mammalian species (Hsu et al. 2014), is likely to profoundly enhance the value of animal models hitherto considered to be genetically intractable. The power of contemporary molecular human genetics/genomics has already resulted in signal surprises and inevitably will lead to further major advances in our understanding of neural signaling pathways involved in regulating hypothalamic GnRH release. The application of global analyses of hypothalamic gene expression, and thereby the identification of gene networks, associated with neuroendocrine mechanisms governing GnRH release has been introduced by Ojeda's laboratory (Lomniczi et al. 2013), and it is likely that this systems biology approach will see wider use as high throughput sequencing techniques become less expensive.
Major questions remain to be addressed and, in the opinion of the writer, the two most important concern the nature of the neurobiological mechanisms that underlie the generation of the pulsatile mode of GnRH release and the mystery of human puberty. The two are related since human puberty is triggered by a reawakening of GnRH pulse generation. In this regard, optogenetics (Deisseroth 2011), which allows the investigator to selectively activate specific signaling pathways in the brain, would appear to be particularly suitable for interrogating the KNDy neuron model of GnRH pulse generation. Examination of this model would also be greatly aided by a complete ‘wiring’ diagram of the arcuate nucleus, and such a goal is on the horizon as technologies underlying connectomics (Eberle et al. 2015) become more readily available. Finally, as with many other fields, it will also be of interest to witness over the next decade or so to what extent epigenetic mechanisms contribute to transmission of inheritable traits in hypothalamic control systems governing GnRH release.
Declaration of interest
The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of this review.
Funding
This review did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Acknowledgements
The author is most grateful to Dr Robert L Goodman, Department of Physiology and Pharmacology, West Virginia University, for kindly reading the manuscript and for his insightful comments and suggestions. Work conducted in the author's laboratory was supported by the National Institutes of Health (grant numbers HD08610, HD13254 and HD16851).
References
Amoss M, Burgus R, Blackwell R, Vale W, Fellows R & Guillemin R 1971 Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochemical and Biophysical Research Communications 44 205–210. (doi:10.1016/S0006-291X(71)80179-1)
Barry J, Dubois MP & Poulain P 1973 LRF producing cells of the mammalian hypothalamus. A fluorescent antibody study. Zeitschrift für Zellforschung und Mikroskopische Anatomie 146 351–366. (doi:10.1007/BF02346227)
Belchetz PE, Plant TM, Nakai Y, Keogh EJ & Knobil E 1978 Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 202 631–633. (doi:10.1126/science.100883)
Cheng G, Coolen LM, Padmanabhan V, Goodman RL & Lehman MN 2010 The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology 151 301–311. (doi:10.1210/en.2009-0541)
Clark SJ, Ellis N, Styne DM, Gluckman PD, Kaplan SL & Grumbach MM 1984 Hormone ontogeny in the ovine fetus. XVII. Demonstration of pulsatile luteinizing hormone secretion by the fetal pituitary gland. Endocrinology 115 1774–1779. (doi:10.1210/endo-115-5-1774)
Clarke IJ & Cummins JT 1982 The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology 111 1737–1739. (doi:10.1210/endo-111-5-1737)
Deisseroth K 2011 Optogenetics. Nature Methods 8 26–29. (doi:10.1038/nmeth.f.324)
Dierschke DJ, Bhattacharya AN, Atkinson LE & Knobil E 1970 Circhoral oscillations of plasma LH levels in the ovariectomized rhesus monkey. Endocrinology 87 850–853. (doi:10.1210/endo-87-5-850)
Donato J Jr, Cravo RM, Frazao R, Gautron L, Scott MM, Lachey J, Castro IA, Margatho LO, Lee S & Lee C et al. 2011 Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. Journal of Clinical Investigation 121 355–368. (doi:10.1172/JCI45106)
Dubois SL, Acosta-Martinez M, DeJoseph MR, Wolfe A, Radovick S, Boehm U, Urban JH & Levine JE 2015 Positive, but not negative feedback actions of estradiol in adult female mice require estrogen receptor α in kisspeptin neurons. Endocrinology 156 1111–1120. (doi:10.1210/en.2014-1851)
Eberle AL, Selchow O, Thaler M, Zeidler D & Kirmse R 2015 Mission (im)possible – mapping the brain becomes a reality. Microscopy 64 45–55. (doi:10.1093/jmicro/dfu104)
Everett JW & Sawyer CH 1950 A 24-hour periodicity in the “LH-release apparatus” of female rats, disclosed by barbiturate sedation. Endocrinology 47 198–218. (doi:10.1210/endo-47-3-198)
Everett JW, Sawyer CH & Markee JE 1949 A neurogenic timing factor in control of the ovulatory discharge of luteinizing hormone in the cyclic rat. Endocrinology 44 234–250. (doi:10.1210/endo-44-3-234)
Farooqi IS & O'Rahilly S 2014 20 Years of leptin: human disorders of leptin action. Journal of Endocrinology 223 T63–T70. (doi:10.1530/JOE-14-0480)
Forest MG, Sizonenko PC, Cathiard AM & Betrand J 1974 Hypophysogonadal function in humans during the first year of life. I. Evidence for testicular activity in early infancy. Journal of Clinical Investigation 53 819–828. (doi:10.1172/JCI107621)
Frisch RE & Revelle R 1970 Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 169 397–399. (doi:10.1126/science.169.3943.397)
Goding JR, Catt KJ, Brown JM, Kaltenbach CC, Cumming IA & Mole BJ 1969 Radioimmunoassay for ovine luteinizing hormone. Secretion of luteinizing hormone during estrus and following estrogen administration in sheep. Endocrinology 85 133–142. (doi:10.1210/endo-85-1-133)
Gonzalez-Martinez D, De Mees C, Douhard Q, Szpirer C & Bakker J 2008 Absence of gonadotropin-releasing hormone 1 and Kiss1 activation in α-fetoprotein knockout mice: prenatal estrogens defeminize the potential to show preovulatory luteinizing hormone surges. Endocrinology 149 2333–2340. (doi:10.1210/en.2007-1422)
Goodman RL 1978 The site of the positive feedback action of estradiol in the rat. Endocrinology 102 151–159. (doi:10.1210/endo-102-1-151)
Goodman RL & Inskeep EK 2015 Control of the ovarian cycle of the sheep. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 1259–1305. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc.
Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CV, Jafarzadehshirazi MR, Pereira A, Iqbal J, Caraty A & Ciofi P et al. 2007 Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 148 5752–5760. (doi:10.1210/en.2007-0961)
Halasz B & Gorski RA 1967 Gonadotrophic hormone secretion in female rats after partial or total interruption of neural afferents to the medial basal hypothalamus. Endocrinology 80 608–622. (doi:10.1210/endo-80-4-608)
Hanon EA, Lincoln GA, Fustin JM, Dardente H, Masson-Pevet M, Morgan PJ & Hazlerigg DG 2008 Ancestral TSH mechanism signals summer in a photoperiodic mammal. Current Biology 18 1147–1152. (doi:10.1016/j.cub.2008.06.076)
Harris GW 1955 In Neural Control of the Pituitary Gland. London, UK: Edward Arnold.
Harris GW 1969 Ovulation. American Journal of Obstetrics and Gynecology 105 659–669.
Hazlerigg D & Simonneaux V 2015 Seasonal reproduction in mammals. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 1575–1604. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc.
Herbison AE 2015 Physiology of the adult gonadotropin-releasing hormone neuronal network. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 399–467. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc.
Herde MK, Iremonger KJ, Constantin S & Herbison AE 2013 GnRH neurons elaborate a long-range projection with shared axonal and dendritic functions. Journal of Neuroscience 33 12689–12697. (doi:10.1523/JNEUROSCI.0579-13.2013)
Hsu PD, Lander ES & Zhang F 2014 Development and applications of CRISPR–Cas9 for genome engineering. Cell 157 1262–1278. (doi:10.1016/j.cell.2014.05.010)
Jayasena CN, Abbara A, Comninos AN, Nijher GM, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Sridharan M, Mason AJ & Warwick J et al. 2014 Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. Journal of Clinical Investigation 124 3667–3677. (doi:10.1172/JCI75730)
Karsch FJ 1980 Twenty-fifth Annual Bowditch Lecture. Seasonal reproduction: a sage of reversible fertility. Physiologist 23 29–38.
Karsch FJ, Dierschke DJ & Knobil E 1973 Sexual differentiation of pituitary function: apparent difference between primates and rodents. Science 179 484–486. (doi:10.1126/science.179.4072.484)
Karsch FJ, Dahl GE, Hachigian TM & Thrun LA 1995 Involvement of thyroid hormones in seasonal reproduction. Journal of Reproduction and Fertility. Supplement 49 409–422.
Kennedy GC & Mitra J 1963 Body weight and food intake as initiating factors for puberty in the rat. Journal of Physiology 166 408–418. (doi:10.1113/jphysiol.1963.sp007112)
Knobil E 1980 The neuroendocrine control of the menstrual cycle. Recent Progress in Hormone Research 36 53–88.
Knobil E 1992 Remembrance: the discovery of the hypothalamic gonadotropin-releasing hormone pulse generator and of its physiological significance. Endocrinology 131 1005–1006. (doi:10.1210/endo.131.3.1505445)
Knobil E, Plant TM, Wildt L, Belchetz PE & Marshall G 1980 Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone. Science 207 1371–1373. (doi:10.1126/science.6766566)
Krey LC, Butler WR & Knobil E 1975 Surgical disconnection of the medial basal hypothalamus and pituitary function in the rhesus monkey. I. Gonadotropin secretion. Endocrinology 96 1073–1087. (doi:10.1210/endo-96-5-1073)
Lincoln GA & Clarke IJ 1994 Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: evidence for translation of the melatonin signal in the pituitary gland. Journal of Neuroendocrinology 6 251–260. (doi:10.1111/j.1365-2826.1994.tb00580.x)
Lomniczi A, Wright H, Castellano JM, Sonmez K & Ojeda SR 2013 A system biology approach to identify regulatory pathways underlying the neuroendocrine control of female puberty in rats and nonhuman primates. Hormones and Behavior 64 175–186. (doi:10.1016/j.yhbeh.2012.09.013)
Majumdar SS, Mikuma N, Ishwad PC, Winters SJ, Attardi BJ, Perera AD & Plant TM 1995 Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSHβ messenger ribonucleic acid levels at precastration values. Endocrinology 136 1969–1977. (doi:10.1210/endo.136.5.7720645)
Matsuo H, Baba Y, Nair RM, Arimura A & Schally AV 1971 Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochemical and Biophysical Research Communications 43 1334–1339. (doi:10.1016/S0006-291X(71)80019-0)
McArdle CA & Roberson MS 2015 Gonadotropes and gonadotropinreleasing hormone signaling. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 335–397. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc.
Millar RP & Newton CL 2013 Current and future applications of GnRH, kisspeptin and neurokinin B analogues. Nature Reviews. Endocrinology 9 451–466. (doi:10.1038/nrendo.2013.120)
Norman RL & Spies HG 1986 Cyclic ovarian function in a male macaque: additional evidence for a lack of sexual differentiation in the physiological mechanisms that regulate the cyclic release of gonadotropins in primates. Endocrinology 118 2608–2610. (doi:10.1210/endo-118-6-2608)
Oakley AE, Clifton DK & Steiner RA 2009 Kisspeptin signaling in the brain. Endocrine Reviews 30 713–743. (doi:10.1210/er.2009-0005)
Plant TM 1980 The effects of neonatal orchidectomy on the developmental pattern of gonadotropin secretion in the male rhesus monkey (Macaca mulatta). Endocrinology 106 1451–1454. (doi:10.1210/endo-106-5-1451)
Plant TM 2012 A comparison of the neuroendocrine mechanisms underlying the initiation of the preovulatory LH surge in the human. Old World monkey and rodent. Frontiers in Neuroendocrinology 33 160–168. (doi:10.1016/j.yfrne.2012.02.002)
Plant TM & Marshall GR 2001 The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocrine Reviews 22 764–786. (doi:10.1210/edrv.22.6.0446)
Plant TM, Gay VL, Marshall GR & Arslan M 1989 Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. PNAS 86 2506–2510. (doi:10.1073/pnas.86.7.2506)
Plant TM, Terasawa E & Witchel SF 2015 Puberty in non-human primates and man. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 1487–1536. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc.
Pohl CR & Knobil E 1982 The role of the central nervous system in the control of ovarian function in higher primates. Annual Review of Physiology 44 583–593. (doi:10.1146/annurev.ph.44.030182.003055)
Rance NE, Krajewski SJ, Smith MA, Cholanian M & Dacks PA 2010 Neurokinin B and the hypothalamic regulation of reproduction. Brain Research 1364 116–128. (doi:10.1016/j.brainres.2010.08.059)
de Roux N, Genin E, Carel J-C, Matsuda F, Chaussain J-L & Milgrom E 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS 100 10972–10976. (doi:10.1073/pnas.1834399100)
Sarkar DK, Chiappa SA, Fink G & Sherwood NM 1976 Gonadotropin-releasing hormone surge in pro-oestrous rats. Nature 264 461–463. (doi:10.1038/264461a0)
Schwanzel-Fukuda M, Bick D & Pfaff DW 1989 Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Research. Molecular Brain Research 6 311–326. (doi:10.1016/0169-328X(89)90076-4)
Seeburg PH & Adelman JP 1984 Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature 311 666–668. (doi:10.1038/311666a0)
Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM & Hendrick AG et al. 2003 The GPR54 gene as a regulator of puberty. New England Journal of Medicine 349 1614–1627. (doi:10.1056/NEJMoa035322)
Shivers BD, Harlan RE, Morrell JI & Pfaff DW 1983 Absence of oestradiol concentration in cell nuclei of LHRH-immunoreactive neurones. Nature 304 345–347. (doi:10.1038/304345a0)
Sklar CA, Mueller PL, Gluckman PD, Kaplan SL, Rudolph AM & Grumbach MM 1981 Hormone ontogeny in the ovine fetus. VII. Circulating luteinizing hormone and follicle-stimulating hormone in mid- and late gestation. Endocrinology 108 874–880. (doi:10.1210/endo-108-3-874)
Szentagothai J, Mess B & Halasz B 1968 In Hypothalamic Control of the Anterior Pituitary, 3rd Edition. Budapest, Hungary: Akademiai Kiado.
Terasawa E, Guerrier KA & Plant TM 2013 Kisspeptin and puberty in mammals. Advances in Experimental Medicine and Biology 784 253–273. (doi:10.1007/978-1-4614-6199-9_12)
Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR & Ozbek MN et al. 2009 TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nature Genetics 41 354–358. (doi:10.1038/ng.306)
Tsutsui K, Saigoh E, Ukena K, Teranishi H, Fujisawa Y, Kikuchi M, Ishii S & Sharp PJ 2000 A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochemical and Biophysical Research Communications 275 661–667. (doi:10.1006/bbrc.2000.3350)
Tsutsui K, Ubuka T, Bentley GE & Kriegsfeld LJ 2012 Gonadotropin-inhibitory hormone (GnIH): discovery, progress and prospect. General and Comparative Endocrinology 177 305–314. (doi:10.1016/j.ygcen.2012.02.013)
Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W & Sawchenko P et al. 1988 Chemical and biological characterization of the inhibin family of protein hormones. Recent Progress in Hormone Research 44 1–34.
Wakabayashi Y, Nakada T, Murata K, Ohkura S, Mogi K, Navarro VM, Clifton DK, Mori Y, Tsukamura H & Maeda K et al. 2010 Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat. Journal of Neuroscience 30 3124–3132. (doi:10.1523/JNEUROSCI.5848-09.2010)
Waldhauser F, Weissenbacher G, Frisch H & Pollak A 1981 Pulsatile secretion of gonadotropins in early infancy. European Journal of Pediatrics 137 71–74. (doi:10.1007/BF00441173)
Wierman ME, Kiseljak-Vassiliades K & Tobet S 2011 Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Frontiers in Neuroendocrinology 32 43–52. (doi:10.1016/j.yfrne.2010.07.005)
Wilson RC, Kesner JS, Kaufman JM, Uemura T, Akema T & Knobil E 1984 Central electrophysiologic correlates of pulsatile luteinizing hormone secretion in the rhesus monkey. Neuroendocrinology 39 256–260. (doi:10.1159/000123988)
Wray S, Grant P & Gainer H 1989 Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. PNAS 86 8132–8136. (doi:10.1073/pnas.86.20.8132)
Yeo SH & Herbison AE 2014 Estrogen-negative feedback and estrous cyclicity are critically dependent upon estrogen receptor-α expression in the arcuate nucleus of adult female mice. Endocrinology 155 2986–2995. (doi:10.1210/en.2014-1128)
Yoshimura T, Yasuo S, Watanabe M, Iigo M, Yamamura T, Hirunagi K & Ebihara S 2003 Light-induced hormone conversion of T4 to T3 regulates photoperiodic response of gonads in birds. Nature 426 178–181. (doi:10.1038/nature02117)
Zeleznik AJ & Plant TM 2015 Control of the menstrual cycle. In Knobil and Neill's Physiology of Reproduction, 4th edn, pp 1307–1361. Eds TM Plant & AJ Zeleznik. San Diego, CA, USA: Elsevier, Inc
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425–432. (doi:10.1038/372425a0)
This paper is part of a thematic review section on 60 years of neuroendocrinology. The Guest Editors for this section were Ashley Grossman and Clive Coen.